Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C
NCT: NCT07662083 · NOT_YET_RECRUITING
Brief Summary
This study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in adults with constipation-predominant irritable bowel syndrome (IBS-C). Participants will be randomized to receive either active or sham stimulation using a non-invasive auricular device over a 60-day period. The primary objectives are to assess changes in symptom severity and quality of life using validated instruments, including the IBS Symptom Severity Scale (IBS-SSS) and the IBS Quality of Life questionnaire (IBS-QOL). Secondary assessments include safety and participant compliance. This study aims to determine whether ta-VNS is an effective non-invasive therapeutic modality for improving symptoms and quality of life in patients with IBS-C.
Frequently Asked Questions
What is Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C?
Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C is a clinical trial registered under NCT07662083. Current status: NOT_YET_RECRUITING.
What is the status of NCT07662083?
The current status of NCT07662083 (Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C) is: NOT_YET_RECRUITING.
When did Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C start?
Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C started on 2026-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.